Abstract accepted

 

30 January, 12:30
Percutaneous – Moderator: Mario Bezzi

PHASE 3 RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF RADIOFREQUENCY ABLATION + LYSO-THERMOSENSITIVE LIPOSOMAL DOXORUBICIN FOR UNRESECTABLE 3-7CM HEPATOCELLULAR CARCINOMA LESIONS – TRIAL IN PROGRESS
Crocetti L, Wiggermann P, Eisele P, Cubillo A, Borys N

Percutaneous Electrochemotherapy in the treatment of Portal Vein Tumor Thrombosis at Hepatic hilum in patients with hepatocellular carcinoma on cirrhosis: a feasibility study
Tarantino L, Busto G, Nasto A, Raffaele F, Cacace L, Talamo M, Accardo C, Bortone S,  Gallo P, Tarantino P, Nasto RA, Di Minno MND, Ambrosino P.

Laser ablation versus radiofrequency ablation: a prospective non-inferiority randomized clinical trial.
Di Costanzo GG

Percutaneous Image-guided Irreversible Electroporation for the treatment of unresectable hepato-biliary-pancreatic cancer.
Belfiore MP

31 January, 12:20
Intra-arterial: – Moderator: Peter Popovic

Balloon-Occluded Trans-arterial Embolization: How and why?
Bellini D, Pelle G, Cianni R

“Trans-radial access (TRA) for TACE and Hepatic Arterial Infusion Chemotherapy (HAIC) of Primary and metastatic liver cancer.
Aliberti C, Carandina R, Sarti R, Pizzirani E, Ramondo G, Mulazzani L,  Fiorentini G

Trans-arterial chemoembolization using Degradable Starch Microspheres transcatheter arterial chemo-embolization (DSM-TACE) in advanced HCC
Poggi CG, Massa Saluzzo C, Montagna B, Palumbo I

31 January, 17:30
Other Tumors: – Moderator: Hugo Rio Tinto

Robotic resection and intraoperative robot assisted radiofrequency ablation of colon cancer liver metastases: a case report.
Laiolo E, Puliti A, Misitano P, Pieraccini M, Bianchi PP

Chemosaturation with percutaneous hepatic perfusion: technical considerations and early experience in patients with unresectable intrahepatic cholangiocarcinoma.
Wacker F, Vogel A, Bruening R, Ferrucci PF, López EV, Prevoo W, Radeleff B, Trillaud H, Tselikas L, Wiggermann P, Kirstein M, Marquardt S